COLUCCELLI, SARA
 Distribuzione geografica
Continente #
AS - Asia 2.428
EU - Europa 1.527
NA - Nord America 1.137
AF - Africa 155
SA - Sud America 103
OC - Oceania 2
Totale 5.352
Nazione #
US - Stati Uniti d'America 1.105
IT - Italia 889
VN - Vietnam 753
CN - Cina 624
SG - Singapore 508
HK - Hong Kong 151
KR - Corea 126
DE - Germania 111
NL - Olanda 92
BR - Brasile 78
IN - India 74
FR - Francia 67
SE - Svezia 63
CI - Costa d'Avorio 50
GB - Regno Unito 50
FI - Finlandia 44
CH - Svizzera 42
JP - Giappone 38
SC - Seychelles 36
IE - Irlanda 29
RU - Federazione Russa 27
ID - Indonesia 24
PH - Filippine 21
PK - Pakistan 20
BD - Bangladesh 19
ES - Italia 19
TG - Togo 18
CA - Canada 17
AT - Austria 16
ZA - Sudafrica 13
AR - Argentina 12
JO - Giordania 12
MK - Macedonia 12
MX - Messico 11
BG - Bulgaria 10
TR - Turchia 10
CZ - Repubblica Ceca 9
DZ - Algeria 9
NG - Nigeria 9
PL - Polonia 9
TH - Thailandia 9
TW - Taiwan 8
UA - Ucraina 8
RO - Romania 7
EG - Egitto 6
IR - Iran 6
LT - Lituania 6
BE - Belgio 5
IQ - Iraq 5
EC - Ecuador 4
UG - Uganda 4
AE - Emirati Arabi Uniti 3
CL - Cile 3
CO - Colombia 3
HR - Croazia 3
MA - Marocco 3
PT - Portogallo 3
SA - Arabia Saudita 3
UZ - Uzbekistan 3
AU - Australia 2
GE - Georgia 2
MQ - Martinica 2
SK - Slovacchia (Repubblica Slovacca) 2
AZ - Azerbaigian 1
CG - Congo 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
EE - Estonia 1
ET - Etiopia 1
GH - Ghana 1
JM - Giamaica 1
KG - Kirghizistan 1
KH - Cambogia 1
KZ - Kazakistan 1
LB - Libano 1
ML - Mali 1
MM - Myanmar 1
MY - Malesia 1
NO - Norvegia 1
NP - Nepal 1
OM - Oman 1
PE - Perù 1
PY - Paraguay 1
SI - Slovenia 1
SN - Senegal 1
SO - Somalia 1
TN - Tunisia 1
VE - Venezuela 1
Totale 5.352
Città #
Singapore 367
Bologna 338
Hefei 272
Ho Chi Minh City 220
Ashburn 217
Hanoi 183
Hong Kong 135
Seoul 123
San Jose 85
Chandler 63
Milan 53
Abidjan 50
Dallas 50
Santa Clara 47
Los Angeles 46
Council Bluffs 45
Beijing 41
Frankfurt am Main 36
Helsinki 35
Boardman 34
New York 34
Bern 32
Dong Ket 30
Da Nang 29
Dublin 29
Tokyo 29
Bengaluru 24
Haiphong 22
Lauterbourg 21
Florence 19
Munich 19
Rome 19
Southend 19
Lomé 18
Seattle 17
Turin 17
Jakarta 16
Paris 16
Redmond 16
Woodbridge 16
Amsterdam 14
Fairfield 13
Nuremberg 13
Amman 12
Biên Hòa 12
Chicago 12
Naples 12
Princeton 12
Redondo Beach 12
Vienna 12
Johannesburg 11
Modena 11
Rimini 11
Bắc Ninh 10
Houston 10
Hyderabad 10
Sofia 10
Buffalo 9
Cambridge 9
Casalecchio di Reno 9
Prilep 9
Shanghai 9
Verona 9
Wilmington 9
Barcelona 8
Hải Dương 8
Parma 8
San Lazzaro di Savena 8
Thái Nguyên 8
Tongling 8
Xi'an 8
Abeokuta 7
Ferrara 7
Guangzhou 7
Mexico City 7
Montreal 7
Orem 7
Vũng Tàu 7
Warsaw 7
Atlanta 6
Bari 6
Berlin 6
Castel Maggiore 6
Cavaion Veronese 6
Chennai 6
Dhaka 6
Falkenstein 6
Genoa 6
Nha Trang 6
Quận Bình Thạnh 6
São Paulo 6
Tân Tiến 6
Algiers 5
Ann Arbor 5
Bến Tre 5
Can Tho 5
Lappeenranta 5
Manduria 5
Pittsburgh 5
Reggio Emilia 5
Totale 3.372
Nome #
Inducing respiratory complex I impairment elicits an increase in PGC1α in ovarian cancer 309
Prognostic Impact of Pathologic Features in Molecular Subgroups of Endometrial Carcinoma 278
Multi-Gene Next-Generation Sequencing Panel for Analysis of BRCA1/BRCA2 and Homologous Recombination Repair Genes Alterations Metastatic Castration-Resistant Prostate Cancer 264
Homologous Recombination Deficiency (HRD) Status in Rare Histotypes of Ovarian Carcinomas: A Single-Center Experience 255
Plasma-activated Ringer's Lactate Solution Displays a Selective Cytotoxic Effect on Ovarian Cancer Cells 253
An analysis of clinical, surgical, pathological and molecular characteristics of endometrial cancer according to mismatch repair status. A multidisciplinary approach 245
MicroRNA and Metabolic Profiling of a Primary Ovarian Neuroendocrine Carcinoma Pulmonary-Type Reveals a High Degree of Similarity with Small Cell Lung Cancer 243
Integrated clinicopathologic and molecular analysis of endometrial carcinoma: Prognostic impact of the new ESGO-ESTRO-ESP endometrial cancer risk classification and proposal of histopathologic algorithm for its implementation in clinical practice 239
HLA Class I Loss in Endometrial Carcinoma: Differences in the Immunosurveillance Pattern in Molecular Subtypes 219
Accuracy of World Health Organisation-grade parameters (necrosis and mitotic activity) and foci of vascular invasion in predicting prognosis of papillary thyroid carcinoma. A case–control validation study 217
Arid1a and ctnnb1/β-catenin molecular status affects the clinicopathologic features and prognosis of endometrial carcinoma: Implications for an improved surrogate molecular classification 216
Immunomagnetic enrichment coupled to PAX8/TP53 molecular pathology approach increases sensitivity in the detection of ovarian cancer cells in ascites 215
Expanding the Spectrum of BRAF Non-V600E Mutations in Thyroid Nodules: Evidence-Based Data from a Tertiary Referral Centre 199
Gut Microbiota Dynamics during Chemotherapy in Epithelial Ovarian Cancer Patients Are Related to Therapeutic Outcome 198
Insights into the impact of chromosome 3p mutations in advanced renal cell carcinoma treated with immune-based combinations or targeted therapy: A single-center experience 193
Potential Prognostic Role of 18F-FDG PET/CT in Invasive Epithelial Ovarian Cancer Relapse. A Preliminary Study 184
BRAF and MLH1 Analysis Algorithm for the Evaluation of Lynch Syndrome Risk in Colorectal Carcinoma Patients: Evidence-Based Data from the Analysis of 100 Consecutive Cases 180
Chromosome 3p gene alterations as biomarkers for immunocombinations in metastatic renal cell carcinoma: A hypothesis-generating analysis 169
Mesonephric-like adenocarcinomas of the ovary: pathological and molecular characterisation of a case series. 163
Morpho-molecular approach (NGS plus digital PCR) in diagnosis of malignant biliary strictures 156
Association of the Genomic Profile of Medullary Thyroid Carcinoma with Tumor Characteristics and Clinical Outcomes in an International Multicenter Study 155
Exploring the Role of TERT in Thyroid Cancer: A Systematic Review 149
Integrated clinicopathological and molecular analysis of endometrial carcinoma: prognostic impact of the new ESGO-ESTRO-ESP endometrial cancer risk classification 140
Molecular pathology of endocrine gland tumors: genetic alterations and clinicopathologic relevance 109
A clinically applicable integrated molecular, immunohistochemical and histological approach for endometrial carcinoma. 99
EIF1AX mutations in thyroid nodules: analysis of a series of 1095 consecutive cases. 97
Corrigendum to “Exploring the role of TERT in thyroid cancer: A systematic review” [Crit. Rev. Oncol./Hematol. 213 (2025) 104792] (Critical Reviews in Oncology / Hematology (2025) 213, (S1040842825001805), (10.1016/j.critrevonc.2025.104792)) 81
Endometrial carcinoma and immune escape: prognostic relevance of HLA class I loss in NSMP subtype 77
The Prognostic Impact of ARID1A Alteration in a Cohort of Molecular Classified Endometrial Carcinomas 57
ESR1 analysis of liquid biopsy in breast cancer, one-year routine experience of an Italian clinical referral center 55
Somatic genetic alterations in the development and progression in thyroid tumors of follicular cells 36
Totale 5.450
Categoria #
all - tutte 13.249
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.249


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202137 0 0 0 0 0 0 0 0 0 1 3 33
2021/2022225 2 12 10 25 16 7 6 18 6 11 72 40
2022/2023563 21 28 18 52 32 40 20 47 120 28 76 81
2023/2024383 44 31 30 26 31 50 12 46 26 19 21 47
2024/20251.195 76 68 106 71 97 56 91 48 42 112 166 262
2025/20262.901 341 451 275 259 189 121 452 105 524 184 0 0
Totale 5.450